TUMORES DEL SISTEMA NERVIOSO EN NEUROFIBROMATOSIS TIPO 1: REVISIÓN Y ACTUALIZACIÓN
DOI:
https://doi.org/10.51437/nj.v27i1.174Palabras clave:
Neurofibromatosis tipo 1; Glioma; Neoplasias cerebrales; Neurofibroma; Tumores malignos de la vaina del nervio periférico; Neuropatología.Resumen
Introducción: Se ha descrito que las personas con Neurofibromatosis tipo 1 (NF1) son propensos a presentar tumores en diferentes órganos y sistemas. El objetivo de este trabajo fue realizar una revisión de la literatura sobre los tumores del sistema nervioso que se han asociado con esta condición genética.
Citas
Alturkustani, M. and Ang, L.-C. (2012), “Rosette-forming glioneuronal tumour of the 4th ventricle in a NF1 patient”, The Canadian Journal of Neurological Sciences. Le Journal CanadienDes Sciences Neurologiques, Vol. 39 No. 1, pp. 95–96.
Arita, H., Narita, Y., Ohno, M., Miyakita, Y., Okita, Y., Ide, T. and Shibui, S. (2013), “Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report”, Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery, Vol. 29 No. 2, pp. 341–345.
Campen, C.J. and Gutmann, D.H. (2018), “Optic Pathway Gliomas in Neurofibromatosis Type 1”, Journal of Child Neurology, Vol. 33 No. 1, pp. 73–81.
Campian, J. and Gutmann, D.H. (2017), “CNS Tumors in Neurofibromatosis”, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, Vol. 35 No. 21, pp. 2378–2385.
Cheong, J.-H., Kim, C.-H., Kim, J.-M. and Oh, Y.-H. (2010), “Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report”, Clinical Neurology and Neurosurgery, Vol. 112 No. 8, pp. 701–706.
Eoli, M., Saletti, V. and Finocchiaro, G. (2019), “Neurological malignancies in neurofibromatosis type 1”, Current Opinion in Oncology, Vol. 31 No. 6, pp. 554–561.
Fangusaro, J., Onar-Thomas, A., Poussaint, T.Y., Wu, S., Ligon, A.H., Lindeman, N., Banerjee, A., et al. (2019), “LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B”, Neuro-Oncology, Vol. 21 No. Supplement_2, pp. ii98–ii99.
Fried, I., Tabori, U., Tihan, T., Reginald, A. and Bouffet, E. (2013), “Opticpathway gliomas: a review”, CNS Oncology, Vol. 2 No. 2, pp. 143–159.
Gutmann, D.H. (2008), “Using Neurofibromatosis-1 to Better Understand and Treat Pediatric Low-Grade Glioma”, Journal of Child Neurology, Vol. 23 No. 10, pp. 1186–1194.
Gutmann, D.H., Ferner, R.E., Listernick, R.H., Korf, B.R., Wolters, P.L. and Johnson, K.J. (2017), “Neurofibromatosis type 1”, Nature Reviews. Disease Primers, Vol. 3, p. 17004.
Hariharan, S., Donahue, J.E., Garre, C., Origone, P. and Grewal, R.P. (2006), “Clinicopathologic and genetic analysis of siblings with NF1 and adult-onset gliomas”, Journal of the Neurological Sciences, Vol. 247 No. 1, pp. 105–108.
Helfferich, J., Nijmeijer, R., Brouwer, O.F., Boon, M., Fock, A., Hoving, E.W., Meijer, L., et al. (2016), “Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas”, Critical Reviews in Oncology/Hematology, Vol. 104, pp. 30–41.
Horiguchi, S., Mitsuya, K., Watanabe, R., Yagishita, S. and Nakasu, Y. (2011), “Pleomorphicxanthoastrocytoma and moyamoyadisease in a patientwith neurofibromatosis type 1 - case report -”, Neurologia Medico-Chirurgica, Vol. 51 No. 4, pp. 310–314.
Hsieh, M.-S., Ho, J.T.-M., Lin, L.-W., Tu, P.-H., Perry, A. and Huang, A.P.-H. (2012), “Cerebellaranaplasticpilocyticastrocytoma in a patientof neurofibromatosis type-1: case reportand reviewoftheliterature”, ClinicalNeurology and Neurosurgery, Vol. 114 No. 7, pp. 1027–1029.
Hu, J., Western, S. and Kesari, S. (2016), “Brainstem Glioma in Adults”, Frontiers in Oncology, Vol. 6, available at:https://doi.org/10.3389/fonc.2016.00180.
Jhas, S., Henriques, L., Hawkins, C., Bouffet, E. and Rutka, J.T. (2009), “An intracranial leiomyosarcoma in a child with neurofibromatosis type 1”, The Canadian Journal of Neurological Sciences. Le Journal CanadienDes Sciences Neurologiques, Vol. 36 No. 4, pp. 491–495.
Kemp, S., Achan, A., Ng, T. and Dexter, M. a. J. (2012), “Rosette-forming glioneuronal tumour of the lateral ventricle in a patient with neurofibromatosis 1”, Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, Vol. 19 No. 8, pp. 1180–1181.
Khanani, M.F., Hawkins, C., Shroff, M., Dirks, P., Capra, M., Burger, P.C. and Bouffet, E. (2006), “Pilomyxoid astrocytoma in a patient with neurofibromatosis”, Pediatric Blood & Cancer, Vol. 46 No. 3, pp. 377–380.
Kresak, J.L. and Walsh, M. (2016), “Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis”, Journal of Pediatric Genetics, Vol. 5 No. 2, pp. 98–104.
Le, C. and Bedocs, P.M. (2020), “Neurofibromatosis”, StatPearls, StatPearls Publishing, Treasure Island (FL), available at: http://www.ncbi.nlm.nih.gov/books/NBK459329/ (accessed 30 January 2020).
Arita, H., Narita, Y., Ohno, M., Miyakita, Y., Okita, Y., Ide, T. and Shibui, S. (2013), “Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report”, Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery, Vol. 29 No. 2, pp. 341–345.
Campen, C.J. and Gutmann, D.H. (2018), “Optic Pathway Gliomas in Neurofibromatosis Type 1”, Journal of Child Neurology, Vol. 33 No. 1, pp. 73–81.
Campian, J. and Gutmann, D.H. (2017), “CNS Tumors in Neurofibromatosis”, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, Vol. 35 No. 21, pp. 2378–2385.
Cheong, J.-H., Kim, C.-H., Kim, J.-M. and Oh, Y.-H. (2010), “Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report”, Clinical Neurology and Neurosurgery, Vol. 112 No. 8, pp. 701–706.
Eoli, M., Saletti, V. and Finocchiaro, G. (2019), “Neurological malignancies in neurofibromatosis type 1”, Current Opinion in Oncology, Vol. 31 No. 6, pp. 554–561.
Fangusaro, J., Onar-Thomas, A., Poussaint, T.Y., Wu, S., Ligon, A.H., Lindeman, N., Banerjee, A., et al. (2019), “LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B”, Neuro-Oncology, Vol. 21 No. Supplement_2, pp. ii98–ii99.
Fried, I., Tabori, U., Tihan, T., Reginald, A. and Bouffet, E. (2013), “Opticpathway gliomas: a review”, CNS Oncology, Vol. 2 No. 2, pp. 143–159.
Gutmann, D.H. (2008), “Using Neurofibromatosis-1 to Better Understand and Treat Pediatric Low-Grade Glioma”, Journal of Child Neurology, Vol. 23 No. 10, pp. 1186–1194.
Gutmann, D.H., Ferner, R.E., Listernick, R.H., Korf, B.R., Wolters, P.L. and Johnson, K.J. (2017), “Neurofibromatosis type 1”, Nature Reviews. Disease Primers, Vol. 3, p. 17004.
Hariharan, S., Donahue, J.E., Garre, C., Origone, P. and Grewal, R.P. (2006), “Clinicopathologic and genetic analysis of siblings with NF1 and adult-onset gliomas”, Journal of the Neurological Sciences, Vol. 247 No. 1, pp. 105–108.
Helfferich, J., Nijmeijer, R., Brouwer, O.F., Boon, M., Fock, A., Hoving, E.W., Meijer, L., et al. (2016), “Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas”, Critical Reviews in Oncology/Hematology, Vol. 104, pp. 30–41.
Horiguchi, S., Mitsuya, K., Watanabe, R., Yagishita, S. and Nakasu, Y. (2011), “Pleomorphicxanthoastrocytoma and moyamoyadisease in a patientwith neurofibromatosis type 1 - case report -”, Neurologia Medico-Chirurgica, Vol. 51 No. 4, pp. 310–314.
Hsieh, M.-S., Ho, J.T.-M., Lin, L.-W., Tu, P.-H., Perry, A. and Huang, A.P.-H. (2012), “Cerebellaranaplasticpilocyticastrocytoma in a patientof neurofibromatosis type-1: case reportand reviewoftheliterature”, ClinicalNeurology and Neurosurgery, Vol. 114 No. 7, pp. 1027–1029.
Hu, J., Western, S. and Kesari, S. (2016), “Brainstem Glioma in Adults”, Frontiers in Oncology, Vol. 6, available at:https://doi.org/10.3389/fonc.2016.00180.
Jhas, S., Henriques, L., Hawkins, C., Bouffet, E. and Rutka, J.T. (2009), “An intracranial leiomyosarcoma in a child with neurofibromatosis type 1”, The Canadian Journal of Neurological Sciences. Le Journal CanadienDes Sciences Neurologiques, Vol. 36 No. 4, pp. 491–495.
Kemp, S., Achan, A., Ng, T. and Dexter, M. a. J. (2012), “Rosette-forming glioneuronal tumour of the lateral ventricle in a patient with neurofibromatosis 1”, Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, Vol. 19 No. 8, pp. 1180–1181.
Khanani, M.F., Hawkins, C., Shroff, M., Dirks, P., Capra, M., Burger, P.C. and Bouffet, E. (2006), “Pilomyxoid astrocytoma in a patient with neurofibromatosis”, Pediatric Blood & Cancer, Vol. 46 No. 3, pp. 377–380.
Kresak, J.L. and Walsh, M. (2016), “Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis”, Journal of Pediatric Genetics, Vol. 5 No. 2, pp. 98–104.
Le, C. and Bedocs, P.M. (2020), “Neurofibromatosis”, StatPearls, StatPearls Publishing, Treasure Island (FL), available at: http://www.ncbi.nlm.nih.gov/books/NBK459329/ (accessed 30 January 2020).
Descargas
Publicado
2020-12-10
Cómo citar
Orrego-González, E. E., Ávila-Madrigal, J., Velandia-Hurtado, F., & Velez-Van-Meerbeke , A. (2020). TUMORES DEL SISTEMA NERVIOSO EN NEUROFIBROMATOSIS TIPO 1: REVISIÓN Y ACTUALIZACIÓN. Neurociencias Journal, 27(1), 75–95. https://doi.org/10.51437/nj.v27i1.174
Número
Sección
Artículo de revisión
